Cite
MLA Citation
S. Le Gouill et al.. “A NEW BCL‐2 INHIBITOR (S55746/BCL201) AS MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMA: PRELIMINARY RESULTS OF THE FIRST‐IN‐HUMAN STUDY.” Hematological oncology, vol. 35, n.d., pp. 47–48. http://access.bl.uk/ark:/81055/vdc_100047426577.0x000032